Картка документу

НОВІ КОМПОЗИЦІЇ ДЛЯ ЛІКУВАННЯ НЕВРОЛОГІЧНИХ ЗАХВОРЮВАНЬ

Бібліографія

Патент України (на 20 р.)
немає даних
(51)
МПК
A61K 31/44 (2006.01)
A61K 31/64 (2006.01)
A61K 31/135 (2006.01)
A61K 31/138 (2006.01)
A61K 31/155 (2006.01)
A61K 31/167 (2006.01)
A61K 31/17 (2006.01)
A61K 31/18 (2006.01)
A61K 31/192 (2006.01)
A61K 31/197 (2006.01)
A61K 31/4164 (2006.01)
A61K 31/42 (2006.01)
A61K 31/445 (2006.01)
A61K 31/473 (2006.01)
A61K 31/4709 (2006.01)
A61K 31/48 (2006.01)
A61K 31/495 (2006.01)
A61K 31/50 (2006.01)
A61K 31/522 (2006.01)
A61K 31/55 (2006.01)
A61K 31/585 (2006.01)
A61K 35/38 (2015.01)
A61P 25/28 (2006.01)
(11)
115968
(22)
01.03.2012
(24)
25.01.2018
(21)
a201311479
(31)
11305217.9
(32)
01.03.2011
(33)
EP
(31)
61/468,658
(32)
29.03.2011
(33)
US
(41)
11.03.2014, бюл. № 5
(46)
25.01.2018, бюл. № 2
(56)
CARTER M.D. ET AL. The development of new therapeutics for Alzheimer's disease / M/D/ Carter, G.A. Simms, D.F. Weaver // CLINICAL PHARMACOLOGY AND THERAPEUTICS, NATURE PUBLISHING GROUP, US. – 01.01.2010. - vol.88, no.4. - P.475-486
WO 92/19245 А1, 12.11.1992
WO 2010/085352 А2, 29.07.2010
YOSHITAKE ISAMU ET AL. First Clinical Application of the DuraHeart Centrifugal Ventricular Assist Device for a Japanese Patient / I. Yoshitake , A. El-Banayosy, M. Yoda, M. Hata, A. Sezai, T. Niino, S. Wakui, R. Koerfer, K. Minami // ARTIFICIAL ORGANS, (20090901). - vol. 33, no. 9. - P.763-766
ZHAO W. ET AL. Identification of antihypertensive drugs which inhibit amyloid-[beta] protein oligomerization / W. Zhao, J. Wang, L. Ho, K. Ono, D.B. Teplow, G.M. Pasinetti // JOURNAL OF ALZHEIMER'S DISEASE. – 2009, NL LNKD. – 2009. - vol. 16, no. 1. - P.49-57
WO 2008/046014 A1, 17.04.2008
SAWYER G.T. Treatment of Multiple Sclerosis with Tolbutamide/ G.T. SAWYER // JAMA. - vol. 174, no. 5. - 1 October 1960 (1960-10-01). - P.470-473
US 5677344 A, 14.10.1997
US 2006/276411 A1, 07.12.2006
UNGER R.H. ET AL. Tolbutamide-Phenformin in Ketoacidosis-Resistant Patients / R.H. Unger, L.L. Madison, N.W. Carter // JAMA. - vol. 174, no. 17. - 1 January 1960 (1960-01-01). – P.2132-2136
SATYANARAYANA S. ET AL. Pharmacodynamic and Pharmacokinetic Drug Interaction of Mexiletine with Tolbutamide in Rabbits / S. Satyanarayana, M. Nitin, K. Prasad // INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, (20110101). - vol. 45, no. 1. – 2011. - P.40-45 (Absrtact)
WING L.M.H. ET AL. Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition / Wing L.M.H., J.M. Miners // BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, (19851101). - vol. 20, no. 5. – 1985. - P.482-485
NISTICO R. ET AL. The blockade of K(+)-ATP channels has neuroprotective effects in an in vitro model of brain ischemia / R. Nistiko, S. Piccirilli, L. Sebastianelli, G. Nistigo, G. Bernardi, N.B. Mercuri // INTERNATIONAL REVIEW OF NEUROBIOLOGY, ACADEMIC PRESS, LONDON, GB, (20070101). - vol. 82. – 2007. - P.383-395
WO 2009/133141 A2, 05.11.2009
WO 2009/133142 A1, 05.11.2009
WO 2009/133128 A1, 05.11.2009
WO 2009/000406 A1, 31.12.2008
CN 101365451 A, 11.02.2009 (Abstract)
EGASHIRA N. ET AL. Mexiletine Reverses Oxaliplatin-Induced Neuropathic Pain in Rats / N. Egashira, Sh. Hirakawa, T. Kawashiri, T. Yano, H. Ikesue, R. Oishi // JOURNAL OF PHARMACOLOGICAL SCIENCES, (20100101). - vol. 112, no. 4. – 2010. - P.473-476
LEE K.H. ET AL. Neuroprotective effects of mexiletine on motor evoked potentials in demyelinated rat spinal cords / K.H. Lee, D.H. Yoon, M.A. Chung, J.H. Sohn, H.J. Lee., B.H. Lee // NEUROSCIENCE RESEARCH, ELSEVIER, SHANNON, IR (20100501). - vol. 67, no. 1. – 2010 - P.59-64
ATES O. ET AL. Neuroprotective effect of mexiletine in the central nervous system of diabetic rats / O. Ates, S.R. Cayli, E. Altinoz, N. Yucel, A. Kocak, O. Tarim, A. Durak, Y. Turkoz, S. Yologlu // MOLECULAR AND CELLULAR BIOCHEMISTRY, KLUWER ACADEMIC PUBLISHERS, BO, (20060316). - vol. 286, no. 1-2. – 2006. - P.125-131
HEWITT K.E. ET AL. The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury / K.E. Hewitt, P.K. Stys, H.J. Lesiuk // BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, (20010420). - vol. 898, no. 2. – 2001. - P.281-287
KAPTANOGLU E. ET AL. Mexiletine treatment-induced inhibition of caspase-3 activation and improvement of behavioral recovery after spinal cord injury / E. KAPTANOGLU, H. CANER, I. SOLAROGLU, K. KILINC // JOURNAL OF NEUROSURGERY. SPINE, AMERICAN ASSOCIATION OF NEUROLOGICAL SURGEONS, US, (20050701). - vol. 3, no. 1. – 2005 - P.53-56
NISHIYAMA K. ET AL. MEXILETINE FOR PAINFUL ALCOHOLIC NEUROPATHY / K. Nishiyama, M. Sakuta // INTERNAL MEDICINE, JAPANESE SOCIETY OF INTERNAL MEDICINE, TOKYO, JP, (19950601). - vol. 34, no. 6. – 1995. - P.577-579
KAPURAL L. ET AL. Intrathecal Ziconotide for Complex Regional Pain Syndrome: Seven Case Reports / L.Kapural, K. Lokey, M.S. Leong, Sh. Fiekowsky, M. Stanton-Hicks, A.J. Sapienza-Crawford, L.R. Webster // PAIN PRACTICE, (20090604). - vol. 9, no. 4. – 2009. - P.296-303
(85)
01.10.2013
(86)
PCT/EP2012/053565, 01.03.2012
(71)
ФАРНЕКСТ FR
 
ФАРНЕКСТ FR
 
PHARNEXT FR
(72)
Коен Даніель FR; Чумаков Ілья FR; Набірочкін Сєргєй FR; Вьяль Еманюель FR; Ґуедж Мікаель FR
 
Коен Даниель FR; Чумаков Илья FR; Набирочкин Сергей FR; Вьяль Эманюэль FR; Гуэдж Микаэль FR
 
Cohen, Daniel FR; Chumakov, Ilya FR; Nabirochkin, Serguei FR; Vial, Emmanuel FR; Guedj, Mickael FR
(73)
ФАРНЕКСТ FR
 
ФАРНЕКСТ FR
 
PHARNEXT FR
(74)
Слободянюк Оксана Олександрівна
(98)
Слободянюк Оксана Олександрівна
а/с 230, м. Київ, 01042
UA
Формула

Реферат (UK)

Реферат (RU)

Реферат (EN)

Опис